Skip to main content

Amlan International to Sponsor and Present at ANECA 2024 Annual Convention, Focusing on Poultry Industry Growth in Mexico

Written by Customer Service on . Posted in Public Companies.

Amlan International to Sponsor and Present at ANECA 2024

The convention is Mexico’s premier event in the poultry industry and is an ideal platform for Amlan to showcase its innovative mineral-based feed additives designed to optimize animal health.
The convention is Mexico’s premier event in the poultry industry and is an ideal platform for Amlan to showcase its innovative mineral-based feed additives designed to optimize animal health.

CHICAGO, April 17, 2024 (GLOBE NEWSWIRE) — Amlan International, the animal health division of Oil-Dri® Corporation of America, is proud to announce its sponsorship and participation at the XLVIII Annual ANECA Convention, to be held in Veracruz, Mexico from April 23rd to 25th. This year commemorates the 50th anniversary of the National Association of Poultry Science Specialists of Mexico (ANECA), highlighting its pivotal role in assembling top professionals and experts who have significantly propelled the industry’s advancement.

The convention is Mexico’s premier event in the poultry industry and is an ideal platform for Amlan to showcase its innovative mineral-based feed additives designed to optimize animal health. Notably, Amlan recently renewed registration for its flagship biotoxin binder, Calibrin® -Z, available in select international markets, in Mexico. Calibrin-Z stands as a highly effective and dependable defender of the intestinal barrier, shielding poultry and livestock from a broad spectrum of biotoxins known to diminish health, performance, and profit margins.

As part of its participation, Amlan will host a comprehensive 3-hour technical seminar on Improving Performance in Management Programs in the Face of the Challenges of Antibiotic Use held on April 25th from 4:00 p.m. to 7:00 p.m. The seminar will offer valuable insights and expertise, delving into the latest advancements and trends in animal health. The following Amlan speaker presentations will be featured:

  • Trends in the Poultry Industry, presented by Dr. Robin Jarquin, Director, LATAM from 4:10 p.m.- 4:50 p.m.
  • Points of Attention in Field Management Programs, presented by Andrés Soto, Key Account Sales Manager from 4:55 p.m.- 5:30 p.m.
  • Considerations in Nutrition Programs to Promote Optimal Performance, presented by Dr. Cesar Coto, Director Technical Services, LATAM from 5:35 p.m.- 6:25 p.m.
  • Innovation and Mineral Technology, presented by Fernando Malapi, Senior Global Product Manager from 6:30 p.m.- 6:50 p.m.

In addition, attendees are welcome to join the ANECA closing reception sponsored by Amlan International at the Hotel Galeria Plaza Veracruz on April 25th from 8:00 p.m- 12:00 a.m. to engage in insightful conversations with Amlan representatives.

“Producers have come to rely on Calibrin-Z to enhance production performance, and with the product registration renewal in Mexico, we are reaffirming our commitment to supporting our customers in the region,” stated Dr. Robin Jarquin, Director of Latin America at Amlan. “Our products play a crucial role in safeguarding the health and well-being of poultry, contributing to the industry’s impressive growth trajectory.”

“In the last five years, Mexico’s poultry industry has experienced a significant surge, with production projected to reach 3.9 million metric tons,” stated Heath Wessels, Vice President of Sales for the Americas. “We are enthusiastic about our participation in this growth and are well positioned to support the thriving Mexican market.”

In addition to Calibrin-Z, Amlan will highlight Varium®, available in select international markets, designed to reduce pathogenic challenges in the intestinal lumen while fortifying the intestinal barrier, and Phylox®, available in select international markets, a natural alternative to anticoccidial drugs and vaccines. These natural, inventive, and highly efficacious products target critical poultry health and performance challenges, aligning perfectly with the industry’s evolving needs.

For more information about Amlan, please visit https://amlan.com/.

Company Information:

Amlan is the animal health business of Oil-Dri Corporation of America, a leading global manufacturer and marketer of sorbent minerals. Leveraging over 80 years of expertise in mineral science, Oil-Dri Corporation of America, doing business as “Amlan International,” is a publicly traded stock on the New York Stock Exchange (NYSE: ODC). Amlan International sells feed additives worldwide. Product availability may vary by country, associated claims do not constitute medical claims, and may differ based on government requirements.

Contact:

Reagan Culbertson, Vice President of Strategic Marketing, B2B Email: Reagan.culbertson@amlan.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d28624bf-1915-48b5-8aa6-2d02ac348a1d

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.